Thomas Roth Sleep Disorders and Research Center, Henry Ford Health System, Detroit, Michigan.
Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan.
J Clin Sleep Med. 2019 Jul 15;15(7):999-1010. doi: 10.5664/jcsm.7882.
Insomnia is a chief complaint among postmenopausal women, and insomnia impairs daytime functioning and reduces quality of life. Recent evidence supports the efficacy of cognitive behavioral therapy for insomnia (CBTI) for menopausal insomnia, but it remains unclear whether treating insomnia improves daytime function in this population. This study evaluated whether CBTI improves daytime fatigue, energy, self-reported sleepiness, work productivity, and quality of life in postmenopausal women with insomnia, and whether sleep restriction therapy (SRT)-a single component of CBTI-is equally efficacious.
Single-site, randomized control trial. One hundred fifty postmenopausal women (56.44 ± 5.64 years) with perimenopausal or postmenopausal onset or exacerbation of chronic insomnia were randomized to 3 treatment conditions: sleep hygiene education control (SHE), SRT, and CBTI. Blinded assessments were performed at pretreatment, posttreatment, and 6-month follow-up.
CBTI and SRT produced moderate-to-large improvements in fatigue, energy, sleepiness, and work function at posttreatment and 6 months later. The CBTI group reported better quality of life as indicated by substantial improvements in emotional wellbeing and resiliency to physical and emotional problems, whereas the SRT and SHE groups only showed improvements in resiliency to physical problems. Pain complaints decreased as sleep improved but were not associated with specific treatment conditions. Similarly, insomnia remitters reported fewer daytime and nighttime hot flashes, although reductions were not associated with any specific treatment.
CBTI and SRT are efficacious options for postmenopausal women with chronic insomnia. Both interventions improve daytime function, quality of life, and work performance, although CBTI produces superior results including the added benefit of improved emotional health.
Registry: ClinicalTrials.gov; Title: Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes; Identifier: NCT01933295; URL: https://clinicaltrials.gov/ct2/show/record/NCT01933295.
失眠是绝经后女性的主要主诉,失眠会损害白天的功能并降低生活质量。最近的证据支持认知行为疗法治疗更年期失眠(CBTI)的有效性,但尚不清楚治疗失眠是否能改善该人群的白天功能。本研究评估了 CBTI 是否能改善绝经后失眠女性的白天疲劳、能量、自我报告的嗜睡、工作效率和生活质量,以及 CBTI 的单一组成部分——睡眠限制疗法(SRT)是否同样有效。
单站点、随机对照试验。150 名绝经后女性(56.44 ± 5.64 岁)患有围绝经期或绝经后开始或慢性失眠加重,随机分为 3 种治疗条件:睡眠卫生教育对照(SHE)、SRT 和 CBTI。在治疗前、治疗后和 6 个月随访时进行盲法评估。
CBTI 和 SRT 在治疗后和 6 个月后均能显著改善疲劳、能量、嗜睡和工作功能。CBTI 组报告的生活质量更好,表现为情绪健康和对身体和情绪问题的适应能力有显著改善,而 SRT 和 SHE 组仅在对身体问题的适应能力方面有所改善。随着睡眠的改善,疼痛抱怨减少,但与特定的治疗条件无关。同样,失眠缓解者报告白天和夜间潮热减少,尽管减少与任何特定的治疗无关。
CBTI 和 SRT 是治疗绝经后慢性失眠症的有效选择。两种干预措施都能改善白天功能、生活质量和工作表现,尽管 CBTI 能产生更好的结果,包括情绪健康的额外益处。
注册处:ClinicalTrials.gov;标题:更年期失眠的行为治疗;睡眠和白天结果;标识符:NCT01933295;网址:https://clinicaltrials.gov/ct2/show/record/NCT01933295。